Immune cell army fights melanoma in new trial
Disease control
Not yet recruiting
This study tests a new treatment called HS-IT101 for people with advanced melanoma that has not responded to standard therapies. It uses a patient's own tumor-fighting immune cells, grown in a lab and given back as a one-time infusion. The study compares this approach to standard…
Phase: PHASE2 • Sponsor: Qingdao Sino-Cell Biomedicine Co., Ltd. • Aim: Disease control
Last updated May 15, 2026 11:58 UTC